{"access_restricted": false, "aka": ["http://www.loc.gov/item/usrep566399/", "http://www.loc.gov/resource/usrep.usrep566399/", "http://www.loc.gov/item/usrep.usrep566399/"], "campaigns": [], "contributor": ["kagan, elena", "supreme court of the united states"], "date": "2011", "dates": ["2011-01-01T00:00:00Z"], "digitized": true, "extract_timestamp": "2021-06-29T13:40:19.009Z", "group": ["usrep104", "us-report"], "hassegments": false, "id": "http://www.loc.gov/item/usrep566399/", "image_url": ["https://tile.loc.gov/storage-services/service/ll/usrep/usrep566/usrep566399/usrep566399.gif#h=155&w=120"], "index": 17077, "item": {"call_number": ["Call Number: KF101", "Series: Intellectual Property Law", "Series: Volume 566"], "contributors": ["Kagan, Elena (Judge)", "Supreme Court of the United States (Author)"], "date": "20110000", "format": "periodical", "genre": ["Periodical"], "language": ["eng"], "notes": ["Description: U.S. Reports Volume 566; October Term, 2011; Caraco Pharmaceutical Laboratories, LTD. V. Novo Nordisk A/S"], "rights": "no known restrictions on use or reproduction", "source_collection": "U.S. Reports", "subjects": ["Law", "Patents", "Patent infringement", "Law Library", "Supreme Court", "United States", "Government Documents", "Judicial review and appeals", "Prescription drugs", "U.S. Reports", "Common law", "Court opinions", "Judicial decisions", "Court cases", "Court decisions", "Generic drugs", "Food and Drug Administration (F.D.A.)", "Act of infringement", "Generic manufacturer", "Hatch-Waxman Amendments", "Prescription drug use code", "Method of use patents", "Patent infringement counterclaim", "Periodical"], "title": "U.S. Reports: Caraco Pharmaceutical Laboratories, LTD. v. Novo Nordisk A/S, 566 U.S. 399 (2012)."}, "language": ["english"], "mime_type": ["image/gif", "application/pdf"], "online_format": ["image", "pdf"], "original_format": ["periodical"], "other_title": [], "partof": ["u.s. reports: volume 566", "law library of congress", "united states reports (official opinions of the u.s. supreme court)", "u.s. reports: intellectual property law"], "resources": [{"files": 1, "image": "https://tile.loc.gov/storage-services/service/ll/usrep/usrep566/usrep566399/usrep566399.gif", "pdf": "https://tile.loc.gov/storage-services/service/ll/usrep/usrep566/usrep566399/usrep566399.pdf", "url": "https://www.loc.gov/resource/usrep.usrep566399/"}], "shelf_id": "Call Number: KF101 Series: Intellectual Property Law Series: Volume 566", "subject": ["hatch-waxman amendments", "supreme court", "united states", "method of use patents", "court opinions", "periodical", "prescription drug use code", "prescription drugs", "patent infringement", "court cases", "act of infringement", "law library", "intellectual property law", "judicial decisions", "generic manufacturer", "judicial review and appeals", "u.s. reports", "law", "generic drugs", "common law", "patent infringement counterclaim", "court decisions", "food and drug administration (f.d.a.)", "government documents", "patents"], "subject_major_case_topic": ["intellectual property law"], "timestamp": "2021-06-29T13:56:17.426Z", "title": "U.S. Reports: Caraco Pharmaceutical Laboratories, LTD. v. Novo Nordisk A/S, 566 U.S. 399 (2012).", "type": "legacyzoom", "url": "https://www.loc.gov/item/usrep566399/", "loc_id": "usrep566399"}